Search

Neuromod establishes global leadership team following launch of Lenire in Spain

Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.

Karl Strom Joins HearingTracker as Editor in Chief

HearingTracker has appointed Karl Strom as its new Editor in Chief.

The new (digital) face of BIOHIT HealthCare

BIOHIT HealthCare is pleased to announce the launch of its new website, which is designed to make it easier than ever for healthcare professionals to find the information they need.

Ida Institute Celebrates Lise Lotte Bundesen for 15 Years of Leadership Driving Person-Centered Care

Ida Institute Founder Lise Lotte Bundesen will retire as Managing Director in July, 2022. During Bundesen’s 15-year tenure, the nonprofit institute’s impact and influence has grown exponentially.

Soluvos Medical is looking forward to the congress season 2022

The Soluvos team is preparing for the summer break. In the meantime, they can be found at the following events

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

New Audio CARL and CARL Platform Released by AHead Simulations

AHead Simulations brings accessibility and affordability to education and research in hearing healthcare through their release of the All-New Audio CARL and Newly Updated CARL Platform.

The central ENT decontamination model: a help or a hindrance?

According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].

The era of lateral flow tests in ENT

The COVID-19 pandemic brought to light the versatility of lateral flow tests (LFTs), with heavy endorsement from healthcare professionals and a greater awareness among the general public.

Accurately diagnosing reflux to direct personalised treatment

Laryngopharyngeal reflux (LPR) frequently causes severe extra-gastrointestinal symptoms – such as a persistent cough, vocal problems, asthma or difficulty swallowing – that can be easily confused with a common cold and allergies.

KARL STORZ Strengthens its ENT Portfolio with the Acquisition of AventaMed in Ireland

The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.

Sounding It Out: The UKs hottest Audiology Podcast – boost your CPD ‘on the go’!

If you could boost your CPD points while cooking, driving or even exercising…that would be a dream, right? Well now you can!